Episode Details

Back to Episodes
Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study | Louise Cosand | DMCN

Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study | Louise Cosand | DMCN

Episode 462 Published 9 months, 1 week ago
Description

In this podcast, Louise Cosand discusses her paper 'Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study'.

 

The paper is available here: https://doi.org/10.1111/dmcn.16482

 

Follow DMCN on Podbean for more:  https://dmcn.podbean.com/

___

Watch DMCN Podcasts on YouTube:

https://bit.ly/2ONCYiC

__

DMCN Journal:

Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.

 

DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749

___

Find us on Twitter!

@mackeithpress - https://twitter.com/mackeithpress

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us